Duke University Medical Center, Durham, North Carolina, USA
Duke Clinical Research Institute, Durham, North Carolina, USA.
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00317-20.
bacteremia (SAB) is a complicated, high-risk disease. For selected low-risk SAB, the role of oral antibiotic stepdown therapy is unknown. Bupha-Intr et al. report a retrospective cohort of low-risk SAB patients who did well with a short duration of intravenous antibiotics, followed by an additional ∼10 days of oral antibiotics, primarily using beta-lactams. Prospective trials will help further define the efficacy of this approach.
菌血症(SAB)是一种复杂的、高危疾病。对于某些特定的低危 SAB,口服抗生素降阶梯治疗的作用尚不清楚。Bupha-Intr 等人报告了一组低危 SAB 患者的回顾性队列研究,这些患者在接受短疗程静脉抗生素治疗后,接着再使用约 10 天的口服抗生素,主要使用β-内酰胺类药物,效果良好。前瞻性试验将有助于进一步确定这种方法的疗效。